News Daily News Synopsis of New Hypertension Guidelines Renews Concerns and Controversy L.A. McKeown January 22, 2018
News Daily News Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors Michael O'Riordan December 12, 2017
News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017
News Conference News AHA 2017 Big BP Reductions When DASH Diet Combined With Low Sodium Intake Michael O'Riordan November 12, 2017
News Daily News As Hypertension Sweeps China, Awareness, Treatment, and Control Remain Poor Todd Neale October 26, 2017
News Daily News More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA Michael O'Riordan October 24, 2017
News Daily News Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events Todd Neale September 25, 2017
News Daily News New Performance and Quality Metrics for STEMI and NSTEMI Care Michael O'Riordan September 21, 2017
News Daily News Popular CV Risk Calculator Is Not Accurate Among Patients at Low Socioeconomic Standing Yael L. Maxwell August 31, 2017
News Daily News Lower Blood Pressure May Protect Against Cognitive Decline in Adults in Their 70s Todd Neale August 22, 2017
News Features Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana Ashley Lyles July 13, 2017
News Daily News Therapies Aimed at New Genetic Target Show Early Promise for Lowering Triglycerides Todd Neale May 26, 2017
News Daily News Drugs Most Heavily Promoted by Pharma Don’t Necessarily Offer the Best Health Value Todd Neale May 04, 2017
News Daily News Visits Nixed: Efforts to Limit Pharma Reps’ Influence Seem to Bear Fruit Caitlin E. Cox May 02, 2017
News Conference News EAS 2017 Perceived Financial Barriers to Healthcare Worsen Cardiovascular Outcomes Even in Countries With Universal Medical Coverage Yael L. Maxwell April 27, 2017
News Mortality and CVD Decline in Patients With Diabetes, but Biggest Strides Seen for Nonfatal Outcomes Michael O'Riordan April 13, 2017
News Conference News ACC 2017 High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI Michael O'Riordan March 21, 2017
News Conference News ACC 2017 SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab Yael L. Maxwell March 17, 2017